Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myelin Proteins | 9 | 2008 | 90 | 1.100 |
Why?
|
Nerve Regeneration | 5 | 2007 | 105 | 0.630 |
Why?
|
Neurons | 11 | 2018 | 2287 | 0.610 |
Why?
|
Axons | 6 | 2007 | 403 | 0.590 |
Why?
|
Induced Pluripotent Stem Cells | 5 | 2018 | 203 | 0.570 |
Why?
|
Apolipoprotein E4 | 3 | 2018 | 48 | 0.460 |
Why?
|
Pluripotent Stem Cells | 2 | 2012 | 123 | 0.450 |
Why?
|
Receptors, Cell Surface | 5 | 2008 | 862 | 0.400 |
Why?
|
Prosencephalon | 1 | 2011 | 43 | 0.390 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2011 | 96 | 0.360 |
Why?
|
Synapses | 2 | 2011 | 509 | 0.350 |
Why?
|
Embryonic Stem Cells | 1 | 2011 | 301 | 0.320 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 5 | 2001 | 1493 | 0.320 |
Why?
|
Pyramidal Tracts | 2 | 2004 | 57 | 0.300 |
Why?
|
Recovery of Function | 4 | 2005 | 703 | 0.300 |
Why?
|
Spinal Cord Injuries | 3 | 2005 | 374 | 0.290 |
Why?
|
Nogo Proteins | 7 | 2007 | 11 | 0.250 |
Why?
|
Alzheimer Disease | 4 | 2018 | 855 | 0.240 |
Why?
|
Caspase Inhibitors | 2 | 2001 | 95 | 0.220 |
Why?
|
Staurosporine | 3 | 1999 | 143 | 0.220 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2001 | 58 | 0.210 |
Why?
|
Cell Differentiation | 1 | 2011 | 4078 | 0.180 |
Why?
|
Etoposide | 1 | 2001 | 870 | 0.180 |
Why?
|
Central Nervous System | 1 | 2001 | 436 | 0.170 |
Why?
|
Dopamine | 3 | 1999 | 312 | 0.170 |
Why?
|
Apoptosis | 4 | 2001 | 7591 | 0.170 |
Why?
|
Glucose | 1 | 2004 | 1248 | 0.160 |
Why?
|
Argininosuccinic Aciduria | 1 | 2018 | 52 | 0.160 |
Why?
|
Argininosuccinate Lyase | 1 | 2018 | 66 | 0.160 |
Why?
|
alpha7 Nicotinic Acetylcholine Receptor | 1 | 2017 | 57 | 0.150 |
Why?
|
alpha-Synuclein | 1 | 2018 | 118 | 0.150 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 1999 | 324 | 0.150 |
Why?
|
Pars Compacta | 1 | 2017 | 4 | 0.150 |
Why?
|
Growth Cones | 2 | 2008 | 20 | 0.150 |
Why?
|
Proto-Oncogene Proteins | 5 | 2001 | 2488 | 0.150 |
Why?
|
Ventral Tegmental Area | 1 | 2017 | 49 | 0.150 |
Why?
|
Neural Stem Cells | 1 | 2017 | 181 | 0.140 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2017 | 204 | 0.140 |
Why?
|
Nogo Receptor 1 | 5 | 2008 | 10 | 0.140 |
Why?
|
Calcium Signaling | 1 | 2017 | 284 | 0.130 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2017 | 244 | 0.130 |
Why?
|
Chromosome Disorders | 1 | 2017 | 417 | 0.130 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 651 | 0.130 |
Why?
|
Cells, Cultured | 5 | 2018 | 5637 | 0.130 |
Why?
|
Mice | 19 | 2018 | 34495 | 0.130 |
Why?
|
GPI-Linked Proteins | 5 | 2008 | 223 | 0.130 |
Why?
|
Genome | 1 | 2018 | 672 | 0.120 |
Why?
|
Mice, Knockout | 8 | 2017 | 5710 | 0.120 |
Why?
|
Gene Dosage | 1 | 2017 | 829 | 0.120 |
Why?
|
bcl-2-Associated X Protein | 5 | 2001 | 367 | 0.120 |
Why?
|
RNA Interference | 1 | 2018 | 1408 | 0.120 |
Why?
|
Cell Line | 9 | 2017 | 5114 | 0.120 |
Why?
|
Rats | 6 | 2011 | 6086 | 0.120 |
Why?
|
Animals | 21 | 2018 | 59536 | 0.120 |
Why?
|
DNA | 1 | 2001 | 2693 | 0.110 |
Why?
|
bcl-X Protein | 4 | 2001 | 196 | 0.110 |
Why?
|
Myelin Sheath | 2 | 2004 | 149 | 0.110 |
Why?
|
Transfection | 4 | 2011 | 2944 | 0.110 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 2012 | 30 | 0.110 |
Why?
|
Segmental Duplications, Genomic | 1 | 2012 | 83 | 0.110 |
Why?
|
Neurogenesis | 2 | 2012 | 238 | 0.110 |
Why?
|
Endothelial Cells | 1 | 2018 | 1048 | 0.100 |
Why?
|
Myocytes, Cardiac | 1 | 2017 | 764 | 0.100 |
Why?
|
Dendritic Spines | 2 | 2012 | 59 | 0.100 |
Why?
|
Microscopy, Electron | 2 | 2011 | 600 | 0.100 |
Why?
|
Seizures | 1 | 2017 | 989 | 0.100 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 2 | 2002 | 194 | 0.100 |
Why?
|
GTPase-Activating Proteins | 1 | 2012 | 126 | 0.100 |
Why?
|
HEK293 Cells | 2 | 2018 | 1489 | 0.100 |
Why?
|
Brain | 4 | 2012 | 4113 | 0.100 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 1516 | 0.100 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2011 | 101 | 0.090 |
Why?
|
Purines | 1 | 2012 | 273 | 0.090 |
Why?
|
Electrophysiology | 1 | 2011 | 333 | 0.090 |
Why?
|
Gene Duplication | 1 | 2012 | 421 | 0.090 |
Why?
|
Intellectual Disability | 1 | 2017 | 1032 | 0.090 |
Why?
|
Parkinson Disease | 1 | 2017 | 708 | 0.090 |
Why?
|
Motor Activity | 2 | 2004 | 693 | 0.090 |
Why?
|
Proteomics | 1 | 2017 | 1380 | 0.090 |
Why?
|
Hypertension | 1 | 2018 | 1503 | 0.080 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 2265 | 0.080 |
Why?
|
Mice, Transgenic | 5 | 2018 | 4143 | 0.080 |
Why?
|
Growth Inhibitors | 1 | 2008 | 149 | 0.080 |
Why?
|
Carrier Proteins | 2 | 2011 | 2022 | 0.080 |
Why?
|
DNA Primers | 1 | 2011 | 1399 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 1062 | 0.080 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2008 | 122 | 0.080 |
Why?
|
Caspases | 2 | 2001 | 661 | 0.080 |
Why?
|
Endothelium, Vascular | 2 | 2018 | 891 | 0.070 |
Why?
|
Cell Count | 2 | 2004 | 508 | 0.070 |
Why?
|
Hippocampus | 2 | 2002 | 915 | 0.070 |
Why?
|
Neuronal Plasticity | 2 | 2008 | 304 | 0.070 |
Why?
|
Homozygote | 2 | 2018 | 717 | 0.070 |
Why?
|
Plaque, Amyloid | 1 | 2006 | 65 | 0.070 |
Why?
|
Protein Structure, Tertiary | 2 | 2012 | 1487 | 0.070 |
Why?
|
5,7-Dihydroxytryptamine | 1 | 2004 | 1 | 0.060 |
Why?
|
Phospholipid Ethers | 1 | 2004 | 13 | 0.060 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2006 | 137 | 0.060 |
Why?
|
Myelin-Associated Glycoprotein | 1 | 2004 | 17 | 0.060 |
Why?
|
Cornified Envelope Proline-Rich Proteins | 1 | 2004 | 30 | 0.060 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 259 | 0.060 |
Why?
|
Schizophrenia | 1 | 2008 | 369 | 0.060 |
Why?
|
Serotonin Agents | 1 | 2004 | 16 | 0.060 |
Why?
|
Desipramine | 1 | 2004 | 30 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2011 | 1491 | 0.060 |
Why?
|
Evoked Potentials, Motor | 1 | 2004 | 58 | 0.060 |
Why?
|
Disease Models, Animal | 4 | 2018 | 7222 | 0.060 |
Why?
|
Cyclic AMP | 2 | 2002 | 358 | 0.060 |
Why?
|
Blotting, Southern | 1 | 2004 | 406 | 0.060 |
Why?
|
Species Specificity | 2 | 2018 | 777 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 3639 | 0.060 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2004 | 151 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 4821 | 0.060 |
Why?
|
Receptors, Peptide | 1 | 2004 | 86 | 0.060 |
Why?
|
Behavior, Animal | 2 | 2004 | 709 | 0.060 |
Why?
|
Amyloid beta-Peptides | 1 | 2006 | 246 | 0.060 |
Why?
|
Blotting, Northern | 1 | 2004 | 682 | 0.060 |
Why?
|
Axotomy | 1 | 2003 | 10 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2007 | 621 | 0.060 |
Why?
|
Spatial Behavior | 1 | 2003 | 20 | 0.060 |
Why?
|
Fetal Viability | 1 | 2003 | 29 | 0.060 |
Why?
|
Serotonin | 1 | 2004 | 264 | 0.060 |
Why?
|
Transcription Factors | 1 | 2017 | 5270 | 0.060 |
Why?
|
Ganglia, Spinal | 1 | 2004 | 237 | 0.060 |
Why?
|
Sciatic Nerve | 1 | 2003 | 112 | 0.060 |
Why?
|
Schwann Cells | 1 | 2003 | 75 | 0.060 |
Why?
|
Cycloheximide | 2 | 1999 | 97 | 0.050 |
Why?
|
Cloning, Molecular | 1 | 2004 | 1213 | 0.050 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2004 | 330 | 0.050 |
Why?
|
Cytochrome c Group | 1 | 2001 | 71 | 0.050 |
Why?
|
Calpain | 1 | 2001 | 64 | 0.050 |
Why?
|
Subcellular Fractions | 1 | 2001 | 201 | 0.050 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2001 | 116 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2007 | 6942 | 0.050 |
Why?
|
Spinal Cord | 1 | 2004 | 690 | 0.050 |
Why?
|
Humans | 18 | 2018 | 261506 | 0.050 |
Why?
|
Time Factors | 3 | 2004 | 12926 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2011 | 2819 | 0.050 |
Why?
|
1-Methyl-4-phenylpyridinium | 1 | 1999 | 4 | 0.050 |
Why?
|
Genotype | 2 | 2018 | 4109 | 0.040 |
Why?
|
Dopamine Agents | 1 | 1999 | 38 | 0.040 |
Why?
|
Mutation | 4 | 2017 | 15179 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 1555 | 0.040 |
Why?
|
Microfilament Proteins | 1 | 2001 | 487 | 0.040 |
Why?
|
Phenotype | 3 | 2007 | 6295 | 0.040 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2017 | 38 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2011 | 8223 | 0.040 |
Why?
|
Urea Cycle Disorders, Inborn | 1 | 2018 | 80 | 0.040 |
Why?
|
Protein Phosphatase 1 | 1 | 2017 | 79 | 0.040 |
Why?
|
Genetic Therapy | 1 | 2005 | 1616 | 0.040 |
Why?
|
Cell Death | 1 | 1999 | 671 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2001 | 1879 | 0.040 |
Why?
|
Phosphorylation | 3 | 2017 | 4804 | 0.040 |
Why?
|
Sarcoplasmic Reticulum | 1 | 2017 | 191 | 0.040 |
Why?
|
Alleles | 2 | 2017 | 2437 | 0.040 |
Why?
|
Male | 9 | 2018 | 123000 | 0.040 |
Why?
|
Female | 8 | 2018 | 141928 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2017 | 231 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 1999 | 2927 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2004 | 7548 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2001 | 1620 | 0.030 |
Why?
|
Proteins | 1 | 2004 | 1963 | 0.030 |
Why?
|
Kinetics | 1 | 1999 | 2049 | 0.030 |
Why?
|
Stroke | 1 | 2004 | 1144 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 545 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2018 | 644 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 709 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2018 | 1338 | 0.030 |
Why?
|
Tamoxifen | 1 | 2017 | 876 | 0.030 |
Why?
|
Drosophila | 1 | 2018 | 839 | 0.030 |
Why?
|
Brain Mapping | 1 | 2017 | 644 | 0.030 |
Why?
|
Calcium | 1 | 1999 | 1537 | 0.030 |
Why?
|
Proteome | 1 | 2017 | 561 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2017 | 1005 | 0.030 |
Why?
|
Rolipram | 2 | 2002 | 6 | 0.030 |
Why?
|
Bromodeoxyuridine | 2 | 2002 | 139 | 0.030 |
Why?
|
Lesch-Nyhan Syndrome | 1 | 2012 | 5 | 0.030 |
Why?
|
Purinergic P2Y Receptor Agonists | 1 | 2012 | 5 | 0.030 |
Why?
|
Receptors, Purinergic P2Y1 | 1 | 2012 | 19 | 0.030 |
Why?
|
Blood Pressure | 1 | 2018 | 1467 | 0.030 |
Why?
|
Genes, Essential | 1 | 2012 | 48 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2018 | 1129 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2012 | 163 | 0.030 |
Why?
|
Antigens, Differentiation | 2 | 2002 | 238 | 0.030 |
Why?
|
Lentivirus | 1 | 2012 | 169 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2012 | 161 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2018 | 1547 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 259 | 0.020 |
Why?
|
Myocardium | 1 | 2017 | 1313 | 0.020 |
Why?
|
Cell Movement | 2 | 2012 | 2466 | 0.020 |
Why?
|
Cell Survival | 3 | 2002 | 3045 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 280 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 5539 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2012 | 571 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1077 | 0.020 |
Why?
|
Chick Embryo | 1 | 2008 | 242 | 0.020 |
Why?
|
Codon | 1 | 2008 | 241 | 0.020 |
Why?
|
COS Cells | 1 | 2008 | 377 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2018 | 6009 | 0.020 |
Why?
|
Cell Division | 2 | 2002 | 2489 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2008 | 241 | 0.020 |
Why?
|
DNA Fragmentation | 2 | 1998 | 198 | 0.020 |
Why?
|
beta Catenin | 1 | 2012 | 688 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2012 | 834 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2012 | 848 | 0.020 |
Why?
|
Decerebrate State | 1 | 2007 | 2 | 0.020 |
Why?
|
Injections, Intraventricular | 1 | 2007 | 114 | 0.020 |
Why?
|
Adolescent | 2 | 2018 | 31252 | 0.020 |
Why?
|
Biotin | 1 | 2007 | 69 | 0.020 |
Why?
|
Dextrans | 1 | 2007 | 90 | 0.020 |
Why?
|
Child | 2 | 2018 | 29154 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2012 | 1694 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 2216 | 0.020 |
Why?
|
Brain Chemistry | 1 | 2006 | 145 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 4053 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2008 | 1471 | 0.020 |
Why?
|
Fibroblasts | 1 | 2012 | 1682 | 0.020 |
Why?
|
Locomotion | 1 | 2005 | 84 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 6089 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2017 | 7226 | 0.020 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2004 | 47 | 0.020 |
Why?
|
Artifacts | 1 | 2007 | 532 | 0.010 |
Why?
|
Heterozygote | 1 | 2007 | 1020 | 0.010 |
Why?
|
Serotonin Uptake Inhibitors | 1 | 2002 | 3 | 0.010 |
Why?
|
Neural Cell Adhesion Molecule L1 | 1 | 2002 | 14 | 0.010 |
Why?
|
Sialic Acids | 1 | 2002 | 29 | 0.010 |
Why?
|
Colforsin | 1 | 2002 | 59 | 0.010 |
Why?
|
PC12 Cells | 1 | 2002 | 46 | 0.010 |
Why?
|
Sialyltransferases | 1 | 2002 | 23 | 0.010 |
Why?
|
Fluoxetine | 1 | 2002 | 43 | 0.010 |
Why?
|
3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2002 | 31 | 0.010 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2002 | 18 | 0.010 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2002 | 66 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 6150 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2004 | 842 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2002 | 331 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 16273 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2002 | 644 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 17523 | 0.010 |
Why?
|
Emetine | 1 | 1999 | 8 | 0.010 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 1999 | 25 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1998 | 4938 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2002 | 332 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2004 | 2063 | 0.010 |
Why?
|
Mesencephalon | 1 | 1999 | 58 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1999 | 71 | 0.010 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1999 | 94 | 0.010 |
Why?
|
Dactinomycin | 1 | 1999 | 145 | 0.010 |
Why?
|
Oxidopamine | 1 | 1998 | 15 | 0.010 |
Why?
|
Cytosol | 1 | 1999 | 238 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 1999 | 448 | 0.010 |
Why?
|
Vitamin K | 1 | 1998 | 54 | 0.010 |
Why?
|
Aging | 1 | 2007 | 1582 | 0.010 |
Why?
|
Trifluoperazine | 1 | 1997 | 8 | 0.010 |
Why?
|
Neomycin | 1 | 1997 | 38 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 1998 | 217 | 0.010 |
Why?
|
Neuroprotective Agents | 1 | 1999 | 215 | 0.010 |
Why?
|
src Homology Domains | 1 | 1997 | 124 | 0.010 |
Why?
|
Signal Transduction | 2 | 2007 | 11965 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1997 | 611 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1997 | 875 | 0.010 |
Why?
|
Aged | 1 | 2017 | 70117 | 0.010 |
Why?
|
Gene Expression | 1 | 1998 | 3570 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2004 | 32848 | 0.000 |
Why?
|
Protein Kinase Inhibitors | 1 | 1997 | 4757 | 0.000 |
Why?
|